Search





Search





Markets
/
Stocks
/
autl
/

Autolus Therapeutics PLC

AUTL

Add to Watchlist

1.490USD

-0.040-2.61%

Close 07-31 16:00（ET）Quotes delayed by 15 min

396.57MMarket Cap

LossP/E TTM

Autolus Therapeutics PLC

1.490

-0.040-2.61%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

AUTL Cash Flow Statement

You can access the annual and quarterly cash flow statements of Autolus Therapeutics PLC to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

13.56%-65.32M

-77.47%-67.32M

11.52%-67.90M

-42.48%-72.78M

-86.52%-75.56M

-52.76%-37.93M

-90.95%-76.74M

-33.91%-51.08M

4.49%-40.51M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

-59.05%-14.57M

8.19%-31.90M

15.85%-30.81M

6.19%-35.03M

66.97%-9.16M

11.04%-34.75M

-35.93%-36.61M

-55.38%-37.34M

16.64%-27.73M

-59.52%-39.06M

-56.48%-26.93M

9.37%-24.03M

---33.27M

---24.49M

---17.21M

---26.52M

Net income from continuing operations

-2.05%-71.60M

-227.22%-90.33M

3.63%-79.11M

17.76%-47.92M

-33.16%-70.16M

64.23%-27.61M

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-186.34%-77.17M

-7.20%-45.85M

-8.31%-45.55M

-7.42%-39.81M

35.32%-26.95M

-25.83%-42.77M

-26.78%-42.06M

-11.41%-37.06M

2.79%-41.67M

8.91%-33.99M

-3.52%-33.17M

-11.36%-33.27M

-4.68%-42.86M

-36.94%-37.31M

-12.53%-32.05M

-9.91%-29.87M

---40.94M

---27.25M

---28.48M

---27.18M

Operating gains losses

18.53%2.70M

43.48%2.98M

30.96%2.54M

2.56%2.37M

26.08%2.28M

17.01%2.08M

10.05%1.94M

52.71%2.31M

-4.90%1.81M

7.64%1.77M

-1.45%1.76M

-21.21%1.51M

-8.13%1.90M

-21.63%1.65M

-27.00%1.79M

-14.48%1.92M

24.37%2.07M

26.59%2.10M

66.76%2.45M

77.11%2.24M

31.80%1.66M

-69.17%1.66M

28.55%1.47M

134.20%1.27M

-23.06%1.26M

--5.39M

--1.14M

--541.00K

--1.64M

Deferred tax

-103.29%-16.00K

-929.79%-1.17M

107.74%13.00K

418.92%384.00K

309.91%487.00K

130.26%141.00K

29.41%-168.00K

185.06%74.00K

-18.97%-232.00K

-246.08%-466.00K

-48.75%-238.00K

65.61%-87.00K

-12.07%-195.00K

175.95%319.00K

-168.67%-160.00K

-164.05%-253.00K

37.86%-174.00K

68.75%-420.00K

--233.00K

--395.00K

---280.00K

-236.84%-1.34M

----

---399.00K

----

Other non-cash items

258.37%5.50M

-139.14%-5.89M

151.69%6.69M

-445.48%-2.14M

-223.66%-3.48M

573.24%15.05M

-318.71%-12.94M

118.80%620.00K

197.27%2.81M

51.38%-3.18M

11.73%5.92M

-162.93%-3.30M

---2.89M

-217933.33%-6.54M

529500.00%5.30M

--5.24M

-100.00%0.00

---3.00K

100.07%1.00K

--0.00

106.88%11.00K

--0.00

---1.33M

--0.00

---160.00K

----

Change in working capital

6.75%-16.50M

132.92%983.00K

-717.29%-12.35M

-157.05%-22.92M

-28.69%-17.70M

-114.33%-2.99M

120.73%2.00M

-645.38%-8.92M

-9.81%-13.75M

117.68%20.83M

-688.64%-9.65M

521.39%1.64M

-213.81%-12.52M

-56.31%9.57M

75.24%-1.22M

94.73%-388.00K

27.07%-3.99M

107.10%21.91M

19.31%-4.94M

-361.77%-7.36M

-277.38%-5.47M

384.61%10.58M

-2.82%-6.13M

-185.78%-1.59M

82.71%-1.45M

---3.72M

---5.96M

--1.86M

---8.39M

-Change in receivables

74.66%-3.63M

--8.57M

---6.00M

---12.39M

---14.34M

----

-Change in inventory

74.84%-2.54M

-139.06%-10.11M

---8.60M

---11.44M

---10.10M

---4.23M

----

-Change in prepaid expenses

-353.72%-1.84M

178.64%8.67M

-192.21%-13.98M

100.37%25.00K

107.18%726.00K

-160.75%-11.02M

19.55%-4.79M

-254.40%-6.67M

-147.07%-10.11M

86.92%18.14M

44.23%-5.95M

194.03%4.32M

22.04%-4.09M

-65.91%9.71M

18.67%-10.67M

-4.58%-4.59M

-7.41%-5.25M

182.90%28.47M

-7.71%-13.12M

-148.78%-4.39M

-244.40%-4.89M

294.77%10.06M

-137.41%-12.18M

54.70%-1.77M

79.18%-1.42M

---5.17M

---5.13M

---3.90M

---6.82M

-Change in other current assets

----

--5.00K

-100.00%0.00

--0.00

-100.00%0.00

--0.00

150.08%886.00K

-100.00%0.00

118.75%51.00K

-100.00%0.00

-303.33%-1.77M

134.29%2.04M

-114.35%-272.00K

-34.77%668.00K

-15.78%870.00K

145.48%869.00K

152.46%1.90M

45.66%1.02M

83.16%1.03M

-72.54%354.00K

206.22%751.00K

--703.00K

--564.00K

--1.29M

---707.00K

-Change in other current liabilities

-100.00%0.00

---7.61M

--5.51M

---2.63M

--4.72M

----

Cash from non-recurring investing activities

Cash from operating activities

13.56%-65.32M

-77.47%-67.32M

11.52%-67.90M

-42.48%-72.78M

-86.52%-75.56M

-52.76%-37.93M

-90.95%-76.74M

-33.91%-51.08M

4.49%-40.51M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

-59.05%-14.57M

8.19%-31.90M

15.85%-30.81M

6.19%-35.03M

66.97%-9.16M

11.04%-34.75M

-35.93%-36.61M

-55.38%-37.34M

16.64%-27.73M

-59.52%-39.06M

-56.48%-26.93M

9.37%-24.03M

---33.27M

---24.49M

---17.21M

---26.52M

Investing cash flow

Net cash from continuing investing activities

-67.39%2.69M

-103.71%-885.00K

30.33%12.50M

765.28%7.28M

1446.53%8.24M

1515.17%23.86M

540.12%9.59M

-80.84%841.00K

-85.28%533.00K

133.33%1.48M

-77.96%1.50M

66.25%4.39M

369.78%3.62M

-60.06%633.00K

76.04%6.80M

74.72%2.64M

-59.42%771.00K

-71.03%1.58M

-4.64%3.86M

-40.11%1.51M

-27.95%1.90M

185.89%5.47M

7.09%4.05M

-55.30%2.52M

-64.02%2.64M

--1.91M

--3.78M

--5.64M

--7.33M

Capital expenditures

-67.39%2.69M

-100.00%0.00

30.33%12.50M

765.28%7.28M

1446.53%8.24M

1515.17%23.86M

540.12%9.59M

-80.84%841.00K

-85.28%533.00K

133.33%1.48M

-77.96%1.50M

66.25%4.39M

369.78%3.62M

-60.06%633.00K

76.04%6.80M

74.72%2.64M

-59.42%771.00K

-71.03%1.58M

-4.64%3.86M

-40.11%1.51M

-27.95%1.90M

185.89%5.47M

7.09%4.05M

-55.30%2.52M

-64.02%2.64M

--1.91M

--3.78M

--5.64M

--7.33M

Net cash flow from disposal of fixed assets

-67.39%2.69M

-107.96%-885.00K

-54.03%4.41M

765.28%7.28M

1446.53%8.24M

652.34%11.11M

540.12%9.59M

-80.84%841.00K

-85.28%533.00K

133.33%1.48M

-77.96%1.50M

66.25%4.39M

369.78%3.62M

-60.06%633.00K

76.04%6.80M

74.72%2.64M

-59.42%771.00K

-71.03%1.58M

-4.64%3.86M

-40.11%1.51M

-27.95%1.90M

244.80%5.47M

7.09%4.05M

-55.30%2.52M

-64.02%2.64M

--1.59M

--3.78M

--5.64M

--7.33M

Net cash flow from intangible asset transactions

----

-100.00%0.00

--8.09M

----

--12.74M

----

-100.00%0.00

----

--327.00K

--0.00

Net cash flow from investment products

292.65%98.84M

123.81%85.66M

--48.04M

--103.19M

---51.30M

---359.73M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

261.47%96.15M

122.56%86.54M

470.71%35.55M

11504.88%95.92M

-11072.05%-59.55M

-25870.82%-383.59M

-540.12%-9.59M

80.84%-841.00K

85.28%-533.00K

-133.33%-1.48M

77.96%-1.50M

-66.25%-4.39M

-369.78%-3.62M

60.06%-633.00K

-76.04%-6.80M

-74.72%-2.64M

59.42%-771.00K

71.03%-1.58M

4.64%-3.86M

40.11%-1.51M

27.95%-1.90M

-185.89%-5.47M

-7.09%-4.05M

55.30%-2.52M

64.02%-2.64M

---1.91M

---3.78M

---5.64M

---7.33M

Financing cash flow

Cash flow from continuous financing activities

---2.06M

-105.99%-1.80M

-1058.92%-1.77M

63.06%-768.00K

-100.00%0.00

130365.22%30.01M

4525.00%185.00K

-849.32%-2.08M

81350.51%561.44M

-99.99%23.00K

-96.08%4.00K

---219.00K

-69000.00%-691.00K

51.62%223.51M

144.35%102.00K

-100.00%0.00

-100.00%-1.00K

37505.87%147.41M

-2400.00%-230.00K

4663.64%13.55M

65.96%123.32M

1052.94%392.00K

101.74%10.00K

-100.27%-297.00K

1857650.00%74.31M

--34.00K

---576.00K

--109.40M

--4.00K

Net cash flow from debt Issuance/repayment

----

-100.00%0.00

--0.00

-100.00%0.00

--30.00M

--0.00

--40.00M

----

40.00%70.00M

----

--50.00M

----

Net cash flow from common stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--549.98M

----

49.81%163.85M

100.00%0.00

-100.00%0.00

27802.55%109.38M

-3660.00%-356.00K

4663.64%13.55M

65.96%123.32M

1052.94%392.00K

101.74%10.00K

-100.27%-297.00K

1857650.00%74.31M

--34.00K

---576.00K

--109.40M

--4.00K

Proceeds from stock option exercised by employees

----

-100.00%0.00

-69.57%7.00K

4525.00%185.00K

--125.00K

--285.00K

--23.00K

-96.58%4.00K

----

100.00%0.00

-7.14%117.00K

----

---1.00K

--126.00K

----

Net cash flow from other financing activities

---2.06M

---1.80M

---1.77M

65.15%-768.00K

100.00%0.00

--0.00

-906.39%-2.20M

-4070.91%-28.82M

100.00%0.00

---219.00K

-69000.00%-691.00K

13.52%-10.35M

---15.00K

--0.00

---1.00K

---11.96M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

---2.06M

-105.99%-1.80M

-1058.92%-1.77M

63.06%-768.00K

-100.00%0.00

130365.22%30.01M

4525.00%185.00K

-849.32%-2.08M

81350.51%561.44M

-99.99%23.00K

-96.08%4.00K

---219.00K

-69000.00%-691.00K

51.62%223.51M

144.35%102.00K

-100.00%0.00

-100.00%-1.00K

37505.87%147.41M

-2400.00%-230.00K

4663.64%13.55M

65.96%123.32M

1052.94%392.00K

101.74%10.00K

-100.27%-297.00K

1857650.00%74.31M

--34.00K

---576.00K

--109.40M

--4.00K

Net cash flow

Beginning cash balance

-53.83%105.64M

-86.69%87.62M

-82.27%125.33M

-87.20%97.25M

-4.80%228.81M

156.39%658.54M

129.66%706.96M

121.21%759.54M

-37.21%240.34M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

-5.71%163.37M

0.09%216.76M

12.13%268.89M

101.63%310.68M

-2.92%173.27M

1.75%216.56M

-1.76%239.80M

-27.12%154.09M

-22.42%178.48M

-20.25%212.83M

29.55%244.10M

-2.82%211.43M

--230.05M

--266.88M

--188.41M

--217.56M

Current period cash flow changes

120.36%26.78M

104.19%18.01M

22.12%-37.71M

153.40%28.08M

-125.34%-131.55M

-2502.23%-429.73M

5.02%-48.42M

-48.03%-52.59M

1417.59%519.21M

-107.53%-16.51M

4.52%-50.98M

31.86%-35.52M

5.69%-39.41M

59.67%219.39M

-23.33%-53.39M

-124.35%-52.13M

-148.75%-41.78M

663.23%137.41M

-26.04%-43.29M

25.69%-23.24M

162.38%85.71M

-31.04%-24.40M

6.74%-34.35M

-139.85%-31.27M

212.10%32.67M

---18.62M

---36.83M

--78.46M

---29.14M

Effect of exchange rate changes

-155.90%-1.99M

101.54%589.00K

-109.50%-3.58M

303.03%5.71M

400.25%3.56M

-491.04%-38.22M

505.57%37.72M

-80.39%1.42M

-116.18%-1.19M

-11.82%9.77M

37.13%-9.30M

138.71%7.23M

222.47%7.33M

1409.95%11.08M

-232.32%-14.79M

-1502.55%-18.68M

-466.54%-5.98M

-91.28%734.00K

-150.87%-4.45M

187.92%1.33M

110.90%1.63M

-49.10%8.41M

209.59%8.75M

81.25%-1.52M

-418.42%-14.97M

--16.53M

---7.99M

---8.08M

--4.70M

Ending cash balance

36.16%132.42M

-53.83%105.64M

-86.69%87.62M

-82.27%125.33M

-87.20%97.25M

-4.80%228.81M

156.39%658.54M

129.66%706.96M

121.21%759.54M

-37.21%240.34M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

-5.71%163.37M

0.09%216.76M

12.13%268.89M

101.63%310.68M

-2.92%173.27M

1.75%216.56M

-1.76%239.80M

-27.12%154.09M

-22.42%178.48M

-20.25%212.83M

29.55%244.10M

--211.43M

--230.05M

--266.88M

--188.41M

Free cash flow

18.86%-68.00M

-8.95%-67.32M

6.87%-80.40M

-54.18%-80.06M

-104.18%-83.81M

-134.85%-61.79M

-107.09%-86.33M

-22.07%-51.92M

10.85%-41.05M

-73.10%-26.31M

-7.71%-41.69M

-27.17%-42.54M

-28.60%-46.04M

-41.48%-15.20M

-0.24%-38.70M

12.26%-33.45M

8.77%-35.80M

67.64%-10.74M

10.44%-38.61M

-29.42%-38.12M

-47.14%-39.24M

5.63%-33.20M

-52.51%-43.11M

-28.88%-29.46M

21.20%-26.67M

---35.18M

---28.27M

---22.86M

---33.85M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Autolus Therapeutics PLC Generate?



Autolus Therapeutics PLC generated -283.57M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Autolus Therapeutics PLC's Operating Cash Flow Change Year Over Year?



Autolus Therapeutics PLC's operating cash flow increased by -37.47% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Autolus Therapeutics PLC Spend on Capital Expenditures?



Autolus Therapeutics PLC spent 27.13M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Autolus Therapeutics PLC's Financing Cash Flow Changed?



Autolus Therapeutics PLC used -4.34M in financing activities in the latest quarter.

What is free cash flow and why does it matter for AUTL?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Autolus Therapeutics PLC’s free cash flow in the latest quarter?



Free cash flow was -310.70M reflecting a -28.87% change from the previous year.